Velentium Launches Medical Device Cybersecurity Course with University of Colorado
Students at the University of Colorado Boulder had a new course offering and introduction to the medtech industry via a partnership between the University and Velentium, a Houston-based engineering firm that specializes in the design and manufacturing of therapeutic and diagnostic medical devices.
Garrett Schumacher, cybersecurity lead at Velentium and adjunct professor, led a course on embedded cybersecurity and secure product development. The program gave students both classroom and hands-on experience in the medical device security realm and included a capstone project with a focus on machine learning and artificial intelligence in relation to threat modeling.
“Velentium is committed to educating the next generation of aspiring engineers and plans to expand this initiative to additional universities around the country, ultimately creating a certification course,” said Schumacher. “It was a joy to work with some brilliant-minded students, and we were proud to hire two interns out of the CU Boulder program, providing opportunities for young engineers to enter the industry and experience career advancement.”
“Beyond theoretical concepts, this course allowed us to experience a hands-on approach for network devices and understand hardware hacking,” said Rushikesh Dodamani, one of the students who joined Velentium as an intern after completing the course. “It also helped students understand different steps of the product development lifecycle and the issues present in each step, gaining insight in how to mitigate those problems. The most significant insight I learned during the course was never to give up while testing a device for vulnerabilities. Velentium helped us understand that there are multitudes of techniques to utilize, and in the process, learn something new and have fun while you’re at it.”
Related Articles
-
Old justifications or business reasons for security gaps are obsolesced. We need robust medical device cybersecurity, but we need it in a manner that is workable by both MDMs and HDOs.
-
The UK MHRA has published “Software and Artificial Intelligence as a Medical Device.” The guidance document assembles previous guidances and regulatory requirements for SaMD and AIaMD devices seeking commercialization in the UK market.
-
The omicron variant of the coronavirus has made clear that the impact of the pandemic is far from over, particularly for health systems and hospitals. The ongoing need to limit close contact between providers and patients means technology will continue…
-
This year, the healthcare industry will step up its fight against cyberattacks because the costs and risks to patient care are becoming too great.
